Publication date: November 12, 2024

• 
  

  - Year of incorporation: 2023 (created from the merger of DSM and Firmenich)
  
  - Year added to the AEX: 2023
  
  - Highest share price ever: €125 in September 2024
  
  - Average trading volume: Approximately 400.000 shares per day
  
  - Price performance over the past 12 months:+11.52%

  
  

  Introduction about the company
  
  DSM-Firmenich AG is a leading international company focused on health, nutrition and well-being. The company was formed from the merger of Dutch DSM and Swiss Firmenich in 2023. DSM-Firmenich is headquartered in Kaiseraugst, Switzerland, and is listed on Euronext Amsterdam under the symbol DSM. The organization operates worldwide and is known for its innovative solutions in food supplements, fragrances and flavors, and sustainable life sciences.
  
  Core figures & performance
  
  Because of the 2023 merger, only DSM's annual figures are available from the pre-merger period. In 2022, DSM had sales of €8.4 billion and net income of about €1.7 billion. The company had about 24,000 employees worldwide and provided products and services to customers in sectors such as nutrition, health and personal care. By the end of 2022, DSM-Firmenich's market capitalization was around €20 billion. The dividend policy is focused on stable distributions to shareholders, supported by sustainable and profitable growth.
  
  History & development
  
  DSM was originally founded in 1902 as State Mines in the Netherlands and grew to become a world leader in food ingredients and sustainable materials. Firmenich, founded in 1895 in Switzerland, was a family-owned company specializing in fragrances and flavorings. In 2023, the two companies merged to form DSM-Firmenich, a powerful combination focused on improving health and well-being worldwide. This merger has enabled DSM-Firmenich to strengthen their expertise and market position in various sectors, and offers new opportunities for synergies and innovation.
  
  Sector & competition
  
  DSM-Firmenich operates within the global sectors of food ingredients, fragrances, flavors and health, where competition is provided by companies such as Givaudan, IFF and Kerry Group. The sector is highly competitive and driven by trends in health, sustainability and responsible consumption. DSM-Firmenich stands out for its strong focus on science and innovation, which enables the company to offer products that respond to the growing demand for healthy and sustainable solutions.
  
  Influence of DSM-Firmenich on the AEX
  
  DSM-Firmenich has a weighting of approximately 2.9% in the AEX index (measured in 2024), which gives the company a significant influence on the Dutch stock market index. Due to the nature of its business in food and health ingredients, DSM-Firmenich is sensitive to macroeconomic changes, but the company has a relatively stable share price movement within the AEX. Important developments in health and sustainability could positively influence DSM-Firmenich's share price and thereby impact the broader index.
  
  Investment analysis & outlook
  
  Investment analysts view DSM-Firmenich as a solid investment with growth potential, driven by strong demand for sustainable and healthy products. The merger strengthened the company's strategic position and opened up new opportunities for synergies and scale. Although the industry is sensitive to economic fluctuations, DSM-Firmenich's focus on innovation and sustainability provides a robust foundation for long-term growth. The merger is seen by analysts as a positive step that further enhances DSM-Firmenich's competitiveness.
  
  Below, you can follow DSM-Firmenich's share price performance compared to the AEX over the past year. This shows that DSM-Firmenich is performing consistently within the AEX, and its price movements are highly correlated with global trends in health and sustainability.

  
  
  News & updates
  
  Recently, DSM-Firmenich announced that it will increase its investment in research and development to develop innovative and sustainable solutions within the food and health industry. The company is focusing on expansion in emerging markets and strengthening its position in North and South America. These initiatives are part of DSM-Firmenich's long-term strategy to provide its customers with high-quality products that contribute to a healthier and more sustainable world. For more information on DSM-Firmenich's performance and strategic plans, please visit its official website: DSM-Firmenich.com

1. 
   
   Disclaimer: Investing involves risk. Our analysts are not financial advisors. Always consult an advisor when making financial decisions. The information and tips provided on this website are based on our analysts' own insights and experiences. They are therefore for educational purposes only.